CUV 0.00% $23.75 clinuvel pharmaceuticals limited

not a bad buy-in point

  1. 648 Posts.
    The market didn't give a rip about the Phase II PDT results - I expected that.

    But still, this is a pretty good buy-in point for a trader. I think the company has a pretty good idea the EPP results are good.

    My concern is whether the FDA will allow them to start Phase III (bypassing Phase II) - you never know with the good old FDA.

    I'm am not worried about the EPP results.
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.173B
Open High Low Value Volume
$23.41 $23.88 $22.75 $3.055M 130.4K

Buyers (Bids)

No. Vol. Price($)
1 699 $23.75

Sellers (Offers)

Price($) Vol. No.
$23.89 130 1
View Market Depth
Last trade - 16.10pm 05/06/2020 (20 minute delay) ?
0.000 ( 0.76 %)
Open High Low Volume
$23.40 $23.88 $22.82 12717
Last updated 15.59pm 05/06/2020 (live) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.